-
ARPANSA approves siting licence for ANSTO waste facility
ARPANSA has issued a licence to the Australian Nuclear Science and Technology Organisation (ANSTO) to prepare a site for the Intermediate Level Waste Capacity Increase (ILWCI) facility. -
Study shows sunscreen saves skin
A review led by ARPANSA has shown that sunscreen is safe to use and, when applied correctly, reduces the risk of skin cancer and sunburn. -
Developing the next generation of nuclear safety professionals
ARPANSA announces applications are open for the Australian Public Service Graduate Program. -
Ensuring accurate dose for radiotherapy
Dose accuracy is critical to safe cancer treatment. Dosimetry audits provide assurance that the radiation dose delivered to the patient aligns with the planned dose. -
Aerosol sunscreens inadequate for UV coverage
ARPANSA and the Cancer Council of Victoria have advised Australians to avoid using aerosol sunscreens and stick with creams and lotions for UV protection. -
Report highlights learnings from nuclear medicine incidents
ARPANSA has finalised its report on 2020 radiation safety incidents using data collated from radiation regulators around the country. -
ARPANSA begins world-first review of radio wave environmental impacts
In another world first, ARPANSA and Swinburne University have joined forces to produce a systematic map of the scientific evidence into the impact of radio waves on the environment. -
Feedback sought on radioactive waste advisory
ARPANSA has released a draft advisory note on the public health considerations for disposal of radioactive waste. -
ARPANSA supports Marshall Islands monitoring
The Australian Radiation Protection and Nuclear Safety Agency has partnered with the Republic of the Marshall Islands (RMI) government to support the development of a sovereign radiation monitoring capability in the region. -
Progress on actions from ANSTO safety review
On 29 June 2018, the ARPANSA CEO issued a Direction to ANSTO to initiate an independent safety review following a series of events with safety implications at the ANSTO Health (now Health Products) facility. ARPANSA has been monitoring progress against the implementation plan and is generally satisfied with the actions taken to date. -
ARPANSA 2020-21 annual report tabled
The annual report of the CEO of ARPANSA 2020-2021 was tabled in parliament on Tuesday 19 October 2021 and is now available in the Commonwealth government Transparency Portal. -
ARPANSA to host consultation forum on ANSTO licence application
The Australian Nuclear Science and Technology Organisation (ANSTO), one of ARPANSA’s major licence holders, has submitted an application to increase temporary storage of radioactive waste at their Lucas Heights site. ARPANSA will host a consultation forum on Wednesday 13 October. -
Updated diagnostic reference levels for medical imaging
ARPANSA has published updated diagnostic reference levels for medical imaging. These reference levels help clinics understand typical radiation doses received during medical imaging. -
New opportunities for electromagnetic energy research
ARPANSA has launched a new research framework to facilitate research of electromagnetic energy exposures and health. -
New radiation resource for dental patients
The ARPANSA and the Australian Dental Association (ADA) have joined together to produce a factsheet for patients to explain different types of dental imaging and the associated levels of radiation exposure. -
ICRP to review System of Radiological Protection
The International Commission on Radiological Protection (ICRP) has commenced a review of its System of Radiological Protection. The System provides recommendations for protection of people and the environment from the harmful effects of ionising radiation. -
ARPANSA to host online event on mobile phones and health
In celebration of National Science Week 2021 (14-22 August), ARPANSA will be hosting an online event ‘Mobile phones and health’, with our Electromagnetic Energy (EME) Program Director, Associate Professor Sarah Loughran. -
Cosmetic radiation research opportunity
ARPANSA is pleased to be collaborating with Monash University to support a PhD opportunity to investigate injuries from cosmetic use of non-ionising radiation.